Polycythemia vera (PV) is a myeloproliferative neoplasm (MPN) that is caused by somatic gain-of-function mutations in the jak2 gene in hematopoietic stem and progenitor cells [1], most of which result in the JAK2V617F oncoprotein [1]. This evidence concerns the gene JAK2 and myeloproliferative disorder.